Comparison and Analysis of Clinical Features of Papillary Thyroid Cancer Complicated With Hashimoto's Thyroiditis

被引:1
|
作者
Zheng, Ke [1 ]
Mao, Jingxin [2 ,3 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Breast & Thyroid Surg, Chongqing, Peoples R China
[2] Chongqing Med & Pharmaceut Coll, Chongqing 401331, Peoples R China
[3] Southwest Univ, Coll Pharmaceut Sci, Chongqing 400715, Peoples R China
关键词
Hashimoto's thyroiditis; PTC; inflammation; relationship; clinical features; MANAGEMENT GUIDELINES; RISK; CARCINOMA; NODULES; PATIENT; DISEASE;
D O I
10.1177/11795549241287085
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Hashimoto thyroiditis (HT) combined with papillary thyroid cancer (PTC) is more common in clinical practice, maybe posing a serious threat to the health of patients. It is uncertain whether HT is a risk factor or protective factor for PTC. The aim of the study was to retrospectively explore the effect of HT on the biological behavior of PTC. Methods: A total of 200 patients were included in the study. Among them, 100 patients with PTC without HT were in the control group (PTC group), and 100 cases diagnosed as PTC with HT were in the experimental group (HT + PTC group). The following data were counted and analyzed, respectively: (1) the basic clinicopathologic characteristics of patients; (2) postoperative thyroid function indicators; (3) blood biochemical indicators; (4) liver function indicators; and (5) histopathological report. Results: Compared with the PTC group, women were predominant in the PTC + HT group (P < .05). In addition, the central lymph node metastasis rate, the number of cervical lymph node metastases, and the lateral cervical lymph node metastasis rate were significantly decreased (P < .05). Thyroid peroxidase antibody (TPOAb), thyroid-stimulating hormone (TSH), and thyroglobulin antibody (TGAb) of the thyroid function index were significantly increased, while the thyroglobulin (TG) value was significantly decreased (P < .05). The alkaline phosphatase (ALP) level of the liver function index was significantly decreased, while the lactate dehydrogenase (LDH) level was significantly increased (P < .05). In the pathological examination, a large number of mononuclear cells infiltrated in the lymphocyte follicular stroma. In an ultrasound examination, the boundary definition rate is lower. Conclusion: Women may be more susceptible to PTC or PTC and HT than men. Patients under 55 years old accounted for a larger proportion in PTC + HT than PTC. Hashimoto thyroiditis may play an inhibitory role in the occurrence of PTC, and the presence of HT is a protective factor for PTC.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease
    Zhang, Ling
    Li, Hui
    Ji, Qing-hai
    Zhu, Yong-xue
    Wang, Zhuo-ying
    Wang, Yu
    Huang, Cai-ping
    Shen, Qiang
    Li, Duan-shu
    Wu, Yi
    BMC CANCER, 2012, 12
  • [2] Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients
    Liang, J.
    Zeng, W.
    Fang, F.
    Yu, T.
    Zhao, Y.
    Fan, X.
    Guo, N.
    Gao, X.
    ACTA OTORHINOLARYNGOLOGICA ITALICA, 2017, 37 (05) : 393 - 400
  • [3] Clinico-pathological features of papillary thyroid cancer coexistent with Hashimoto's thyroiditis
    Sarolta, Molnar
    Ferenc, Gyory
    Endre, Nagy
    Gabor, Mehes
    Csaba, Molnar
    ORVOSI HETILAP, 2017, 158 (05) : 178 - 182
  • [4] Hashimoto's Thyroiditis is Not a Negative Contributor to Papillary Thyroid Cancer
    Cetin, Zeynep
    Baser, Ozden
    Guler, Serdar
    EUROPEAN JOURNAL OF THERAPEUTICS, 2022, 28 (01): : 30 - 36
  • [5] Hashimoto's Thyroiditis and the Risk of Papillary Thyroid Cancer in Children
    Gallant, Jean-Nicolas
    Weiss, Vivian L.
    Chen, Sheau-Chiann
    Liang, Jiancong
    Belcher, Ryan H.
    Ye, Fei
    Correa, Hernan
    Wang, Huiying
    CANCERS, 2023, 15 (19)
  • [6] Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer
    Marotta, Vincenzo
    Sciammarella, Concetta
    Chiofalo, Maria Grazia
    Gambardella, Claudio
    Bellevicine, Claudio
    Grasso, Marica
    Conzo, Giovanni
    Docimo, Giovanni
    Botti, Gerardo
    Losito, Simona
    Troncone, Giancarlo
    De Palma, Maurizio
    Giacomelli, Laura
    Pezzullo, Luciano
    Colao, Annamaria
    Faggiano, Antongiulio
    ENDOCRINE-RELATED CANCER, 2017, 24 (09) : 485 - 493
  • [7] Investigating the Association Between Hashimoto's Thyroiditis and Papillary Thyroid Cancer
    Berrios, Adriana I. Baez
    Monaghan, Mathilda
    Brandwein-Weber, Margaret
    van Gerwen, Maaike
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2025, 47 (04): : 1214 - 1222
  • [8] Clinical relationship between Hashimoto's thyroiditis and papillary thyroid cancer
    Ahn, Dongbin
    Heo, Sung Jae
    Park, Ji Hyun
    Kim, Jae Hyug
    Sohn, Jin Ho
    Park, Ji Young
    Park, Sun-Kyun
    Park, Junesik
    ACTA ONCOLOGICA, 2011, 50 (08) : 1228 - 1234
  • [9] Coexistence of papillary thyroid cancer with Hashimoto thyroiditis
    Konturek, Aleksander
    Barczynski, Marcin
    Wierzchowski, Wojciech
    Stopa, Malgorzata
    Nowak, Wojciech
    LANGENBECKS ARCHIVES OF SURGERY, 2013, 398 (03) : 389 - 394
  • [10] The clinical features of papillary thyroid cancer in Hashimoto’s thyroiditis patients from an area with a high prevalence of Hashimoto’s disease
    Ling Zhang
    Hui Li
    Qing-hai Ji
    Yong-xue Zhu
    Zhuo-ying Wang
    Yu Wang
    Cai-ping Huang
    Qiang Shen
    Duan-shu Li
    Yi Wu
    BMC Cancer, 12